Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model
Parasite, 1 4 (1994) 319-324
Published online: 2014-09-29
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Ninety Years of Pentamidine: The Development and Applications of Pentamidine and its Analogs
Bo Zhang, Yushan Jin, Lei Zhang, Hongshuang Wang and Xiaohui WangCurrent Medicinal Chemistry 29 (26) 4602 (2022)
https://doi.org/10.2174/0929867329666220314121446
Nanotechnological approaches for pentamidine delivery
Ilaria Andreana, Valeria Bincoletto, Paola Milla, et al.Drug Delivery and Translational Research 12 (8) 1911 (2022)
https://doi.org/10.1007/s13346-022-01127-4
Antiprotozoal Drug Development and Delivery
Douglas O. Escrivani, Gabriela C. Mattos, Bartira Rossi-Bergmann and Ariane J. Sousa-BatistaTopics in Medicinal Chemistry, Antiprotozoal Drug Development and Delivery 39 181 (2021)
https://doi.org/10.1007/7355_2021_134
Catalytic reduction of 4-nitrophenol to 4- amino phenol by chitosan/TiO2- Fe2O3 nanomaterial
N. Anusuya, C. Pragathiswaran and G. ThulasiMaterials Today: Proceedings 37 3759 (2021)
https://doi.org/10.1016/j.matpr.2020.10.570
Encapsulation of Active Molecules and Their Delivery System
Santanu Sasidharan and Prakash SaudagarEncapsulation of Active Molecules and Their Delivery System 323 (2020)
https://doi.org/10.1016/B978-0-12-819363-1.00017-X
Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major
Jaleh Varshosaz, Bahar Arbabi, Nader Pestehchian, Sedigheh Saberi and Mahdi DelavariInternational Journal of Biological Macromolecules 107 212 (2018)
https://doi.org/10.1016/j.ijbiomac.2017.08.177
Leishmaniases as Re-emerging Diseases
Ariane Sousa-Batista and Bartira Rossi-BergmannLeishmaniases as Re-emerging Diseases (2018)
https://doi.org/10.5772/intechopen.75750
Nano- and Microscale Drug Delivery Systems
Swati Pund and Amita JoshiNano- and Microscale Drug Delivery Systems 439 (2017)
https://doi.org/10.1016/B978-0-323-52727-9.00023-6
Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis
Juan D. Unciti-Broceta, José L. Arias, José Maceira, et al.PLOS Pathogens 11 (6) e1004942 (2015)
https://doi.org/10.1371/journal.ppat.1004942
Anti-leishmanial activities of selenium nanoparticles and selenium dioxide on Leishmania infantum
Saied Soflaei, Abdolhossein Dalimi, Amir Abdoli, et al.Comparative Clinical Pathology 23 (1) 15 (2014)
https://doi.org/10.1007/s00580-012-1561-z
Polymeric colloidal particulate systems: intelligent tools for intracellular targeting of antileishmanial cargos
Shalini Asthana, Pramod K Gupta, Mohini Chaurasia, Anuradha Dube and Manish K ChourasiaExpert Opinion on Drug Delivery 10 (12) 1633 (2013)
https://doi.org/10.1517/17425247.2013.838216
Drug delivery systems in the treatment of African trypanosomiasis infections
Maya Kroubi, Hamadi Karembe and Didier BetbederExpert Opinion on Drug Delivery 8 (6) 735 (2011)
https://doi.org/10.1517/17425247.2011.574122
(2003)
https://doi.org/10.1002/9783527610419.ntls0115
The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro
B. Heurtault, P. Legrand, V. Mosqueira, et al.Annals of Tropical Medicine & Parasitology 95 (5) 529 (2001)
https://doi.org/10.1080/00034983.2001.11813665
Improvement of In Vitro and In Vivo Antileishmanial Activities of 2′,6′-Dihydroxy-4′-Methoxychalcone by Entrapment in Poly( d,l -Lactide) Nanoparticles
Eduardo Caio Torres-Santos, José M. Rodrigues, Davyson L. Moreira, Maria Auxiliadora C. Kaplan and Bartira Rossi-BergmannAntimicrobial Agents and Chemotherapy 43 (7) 1776 (1999)
https://doi.org/10.1128/AAC.43.7.1776
Lack of a nitric-oxide response during the course ofLeishmania infantuminfection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B
C. Bories, C. Coffin, D. Mathieu, et al.Annals of Tropical Medicine & Parasitology 92 (6) 685 (1998)
https://doi.org/10.1080/00034983.1998.11813328
Pentamidine-loaded poly(D,L-lactide) nanoparticles: Adsorption and drug release
Muriel Paul, Abdelkader Laatiris, Hatem Fessi, et al.Drug Development Research 43 (2) 98 (1998)
https://doi.org/10.1002/(SICI)1098-2299(199802)43:2<98::AID-DDR2>3.0.CO;2-K
Physicochemical Characteristics of Pentamidine-Loaded Polymethacrylate Nanoparticles: Implication in the Intracellular Drug Release inLeishmania MajorInfected Mice
M. Paul, R. Durand, Y. Boulard, et al.Journal of Drug Targeting 5 (6) 481 (1998)
https://doi.org/10.3109/10611869808997874
Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model
M Paul, R Durand, H Fessi, et al.Antimicrobial Agents and Chemotherapy 41 (8) 1731 (1997)
https://doi.org/10.1128/AAC.41.8.1731
Pentamidine-loaded poly(d,l-lactide) nanoparticles: physicochemical properties and stability work
M Paul, H Fessi, A Laatiris, et al.International Journal of Pharmaceutics 159 (2) 223 (1997)
https://doi.org/10.1016/S0378-5173(97)00291-3
Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model
Rémy Durand, Muriel Paul, Daniéle Rivollet, et al.International Journal for Parasitology 27 (11) 1361 (1997)
https://doi.org/10.1016/S0020-7519(97)00124-0